Angelika Worner
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.
Journal: Clinical epigenetics
Published: July 10, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model.
Journal: Molecular oncology
Published: September 10, 2025
5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 17, 2022
Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Journal: Nature communications
Published: February 08, 2018
The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
Journal: BMC genomics
Published: August 07, 2015
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
Journal: Oncogene
Published: April 02, 2014
MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon).
Journal: The Journal of biological chemistry
Published: February 01, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026